THE PROMISE
OF CELL THERAPY
Chimeric antigen receptor (CAR) therapy is a new treatment for cancer in which immune cells, either from the patient or from a donor, are genetically engineered to recognize cancer cells to target and destroy them. Currently approved CAR T therapies are revolutionizing the treatment of many blood cancers including B cell leukemias and lymphomas by targeting specific proteins found on these cancers, and there is hope in treating additional cancers including solid tumors by having them recognize new targets.